Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 11/0
-
Market price (% of par)
-
89.19%
-
Total 13F principal
-
$466,618,086
-
Principal change
-
+$12,427,608
-
Total reported market value
-
$431,129,973
-
Number of holders
-
31
-
Value change
-
+$13,185,553
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q4 2022
As of 31 Dec 2022,
NOVOCURE LTD - NOTE 11/0 was held by
31 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$466,618,086
in principal (par value) of the bond.
The largest 10 bondholders included
BRAIDWELL LP, Voya Investment Management LLC, WOLVERINE ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, Aequim Alternative Investments LP, Calamos Advisors LLC, CAPSTONE INVESTMENT ADVISORS, LLC, and SHENKMAN CAPITAL MANAGEMENT INC.
This page lists
33
institutional bondholders reporting positions
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.